| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $5.28 | $5.65 | $6.07 | $5.50 | $4.22 | $5.18 | $4.75 | $3.67 |
| EPS (Diluted) | $5.26 | $5.61 | $6.02 | $5.46 | $4.21 | $5.14 | $4.71 | $3.64 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.0B | $5.8B | $5.7B | $5.4B | $5.5B | $5.0B | $4.7B | $4.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.7B | $0.6B | $0.2B | $0.2B | $0.2B |
| Total Liabilities | $5.4B | $5.2B | $5.1B | $4.8B | $4.9B | $4.4B | $4.1B | $3.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.6B | $0.6B | $0.5B | $0.6B | $0.6B | $0.6B | $0.5B | $0.5B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.8B | $0.2B | $-0.1B | $-0.3B | $-0.4B | $0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $-0.0B | $-0.0B | $-0.0B |
| Financing Cash Flow | $0.1B | $0.1B | $0.2B | $-0.1B | $0.4B | $0.2B | $0.2B | $-0.2B |